Investing.com - Fresenius Medical Care ADR (NYSE: FMS) reported second quarter EPS of $0.70, $0.33 better than the analyst estimate of $0.37. Revenue for the quarter came in at $4.77B versus the consensus estimate of $5.44B.
Fresenius Medical Care ADR's stock price closed at $20.36. It is down -6.00% in the last 3 months and down -22.02% in the last 12 months.
Fresenius Medical Care ADR saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Fresenius Medical Care ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Fresenius Medical Care ADR's Financial Health score is "good performance".
Check out Fresenius Medical Care ADR's recent earnings performance, and Fresenius Medical Care ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar